University of Texas: Study Defines Small-Cell Lung Cancer Subtypes and Distinct Therapeutic Vulnerabilities for Each Type
January 22, 2021
January 22, 2021
HOUSTON, Texas, Jan. 22 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Jan. 21:
Researchers from The University of Texas MD Anderson Cancer Center have developed the first comprehensive framework to classify small-cell lung cancer (SCLC) into four unique subtypes, based on gene expression, and have identified potential therapeutic targets for each type in a study published today in Cancer Cell.
SCLC is known for . . .
Researchers from The University of Texas MD Anderson Cancer Center have developed the first comprehensive framework to classify small-cell lung cancer (SCLC) into four unique subtypes, based on gene expression, and have identified potential therapeutic targets for each type in a study published today in Cancer Cell.
SCLC is known for . . .